New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
NCT05264259 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-08-08
Summary
BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.
Conditions
- BK Virus Infection
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Principal Investigators
-
Samira FAFI-KREMER · University Hospital, Strasbourg, France
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-05
- Primary Completion
- 2022-09-05
- Completion
- 2025-12-01
Countries
- France
Study Locations
More Related Trials
-
Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy
NCT07347769 ·Status: NOT_YET_RECRUITING
-
Salivary Replication of BK Virus in Post-kidney Transplant
NCT07256470 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.
NCT04222023 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
NCT05224583 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation
NCT04506060 ·Status: UNKNOWN
-
Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
NCT05026021 ·Status: ACTIVE_NOT_RECRUITING
-
BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients
NCT01782209 ·Status: COMPLETED
-
Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia
NCT06988072 ·Status: NOT_YET_RECRUITING
-
Immune Registry for BK in Kidney Transplant Recipients
NCT06538961 ·Status: RECRUITING
-
Respiratory Viral Infections in Pediatric Transplantation
NCT02260596 ·Status: COMPLETED
-
Reduction of BK Viremia in Kidney Transplant Patients
NCT04984902 ·Status: WITHDRAWN ·Phase: NA
-
Ciprofloxacin for Prevention of BK Infection
NCT01789203 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant
NCT02049827 ·Status: COMPLETED ·Phase: NA
-
BK Viremia After Renal Transplantation
NCT00684372 ·Status: UNKNOWN ·Phase: NA
-
Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients
NCT04757883 ·Status: TERMINATED
-
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.
NCT03339661 ·Status: COMPLETED ·Phase: PHASE2
-
Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants
NCT00018785 ·Status: COMPLETED ·Phase: NA
-
The Role of B Cells in Kidney Allograft Dysfunction
NCT02294032 ·Status: COMPLETED
-
Molecular Assessment and Profiling of Liver Transplant Recipients
NCT04793360 ·Status: ACTIVE_NOT_RECRUITING
-
Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease
NCT03100682 ·Status: UNKNOWN
-
Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant Recipients
NCT04969614 ·Status: UNKNOWN
-
A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom
NCT06568055 ·Status: COMPLETED
-
Antibody After COVID-19 Vaccination
NCT05057936 ·Status: COMPLETED
-
Anti-infection Therapy Based on mNGS Etiological Diagnosis and Infection After Liver Transplantation
NCT06212115 ·Status: NOT_YET_RECRUITING
-
A Retrospective Review of Infections Usually Observed in Transplant Recipients
NCT00298077 ·Status: COMPLETED